Source: International Congress 2015 – Asthma and lung immunology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vibeke Backer (Copenhagen, Denmark), Vibeke Backer, Kathrine Baines, Heather Powell, Celeste Porsbjerg, Peter Gibson. LATE-BREAKING ABSTRACT: Mast cell markers in adipose tissue, systemic inflammation and asthma. Eur Respir J 2015; 46: Suppl. 59, 1084

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Low lung volume is associated with visceral adipose tissue inflammation Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 LATE-BREAKING ABSTRACT: The heterogeneity of systemic inflammation in bronchiectasis Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Characterisation of adipose tissue macrophage phenotypes in obese asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Airway inflammation in patients with different levels of asthma control Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 LATE-BREAKING ABSTRACT: E-cigarette exposure induces pathological responses that result in lung tissue destruction and airway hyper reactivity in mice. Source: International Congress 2014 – E-cigarettes in different populations Year: 2014 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Chymase-positive mast cells represent a major source for IL-17A in airway inflammation Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Inhibitors of apoptosis proteins in asthmatic airway inflammation Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 MIP-1β is associated with eosinophilic airway inflammation Source: International Congress 2016 – Translational studies in lung disease Year: 2016